Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-label, Controlled, Pivotal Clinical Trial to Evaluate the Efficacy and Safety of Software SAT-014 for the Alleviation of Symptoms Related to Trauma and Stressor-related Disorders

NCT06734858 is registered in ClinicalTrials.gov with S-Alpha Therapeutics, Inc. as lead sponsor.

NCT NCT06734858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-label, Controlled, Pivotal Clinical Trial to Evaluate the Efficacy and Safety of Software SAT-014 for the Alleviation of Symptoms Related to Trauma and Stressor-related Disorders
Lead sponsor
S-Alpha Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 9, 2024
Completion date
May 29, 2025
Enrollment
110 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adjustment disorders, post-traumatic stress disorder